Trials / Recruiting
RecruitingNCT06221267
A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-arm, prospective, multicenter, observational registry study. It plans to enroll 120 migraine patients who meet the inclusion criteria and are treated with rimegepant in selected hospital outpatient clinics in the Greater Bay Area. The main purpose of this study is to observe the effectiveness of rimegepant in treating migraines in a real-world clinical setting, including the impact of rimegepant on the quality of life, functioning, productivity status of migraine patients, and patients' satisfaction with the use of rimegepant in treating migraines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rimegepant | No intervention. The study will record the usage, timing, frequency, and dosage of rimegepant in a real-world clinical setting. |
Timeline
- Start date
- 2024-01-26
- Primary completion
- 2024-05-31
- Completion
- 2024-06-30
- First posted
- 2024-01-24
- Last updated
- 2024-04-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06221267. Inclusion in this directory is not an endorsement.